Solifenacin Succinate Versus Tolterodine 4mg Once Daily

PHASE3CompletedINTERVENTIONAL
Enrollment

1,355

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

October 31, 2004

Study Completion Date

October 31, 2004

Conditions
Urinary Bladder, Overactive
Interventions
DRUG

Solifenacin succinate

oral

DRUG

Tolterodine

Oral

Trial Locations (95)

Unknown

Minsk

Antwerp

Brussels

Ghent

Middleheim

Brno

Bulovce

České Budějovice

Mělník

Prague

Aalborg

Aarhus

Copenhagen

Glostrup Municipality

Herlev

Kolding

Odense

Angers

Bordeaux

Clermont-Ferrand

Lille

Nantes

Paris

Reims

Rouen

Saint-Priest-en-Jarez

Toulouse

Bad Ems

Emmendingen

Frankfurt

Freiburg im Breisgau

Hagenow

Hamburg

Koblenz

Rheinfelden

Trier

Uetersen

Athens

Larissa

Pátrai

Thessaloniki

Budapest

Nyíregyháza

Szolnok

Tatabánya

Montecchio Emilia

Novara

Orbassano

Rome

Sassari

Sesto San Giovanni

Varese

Verona

Apeldoorn

Ede

Eindhoven

Groningen

Nijmegen

Roermond

Tilburg

Zeist

Bodø

Haugesund

Rud

Tønsberg

Moscow

Saint Petersburg

Bratislava

Košice

Martin

Prešov

Skalica

Alicante

Bilbao

Burgos

Llobregat

Madrid

Santiago de Compostela

Seville

Valencia

Valladolid

Gothenburg

Malmo

Nyköping

Stockholm

Kiev

Birmingham

Harrow

Leicester

Liverpool

London

Plymouth

Sheffield

Stevenage

Swansea

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY